GESSI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 17.643
EU - Europa 6.438
AS - Asia 3.146
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
AF - Africa 3
Totale 27.258
Nazione #
US - Stati Uniti d'America 17.626
CN - Cina 2.016
IT - Italia 1.802
UA - Ucraina 1.406
DE - Germania 1.211
TR - Turchia 1.006
GB - Regno Unito 534
SE - Svezia 440
FI - Finlandia 314
BE - Belgio 206
PL - Polonia 172
RU - Federazione Russa 150
FR - Francia 107
HK - Hong Kong 60
AT - Austria 39
NL - Olanda 17
VN - Vietnam 15
CA - Canada 13
CZ - Repubblica Ceca 13
IR - Iran 13
IN - India 12
EU - Europa 7
AU - Australia 6
CL - Cile 6
ES - Italia 6
CH - Svizzera 4
JP - Giappone 4
MX - Messico 4
RO - Romania 4
DZ - Algeria 3
HR - Croazia 3
KR - Corea 3
SG - Singapore 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BR - Brasile 2
IM - Isola di Man 2
IQ - Iraq 2
SA - Arabia Saudita 2
SI - Slovenia 2
UZ - Uzbekistan 2
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
EC - Ecuador 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
ME - Montenegro 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
Totale 27.258
Città #
Woodbridge 2.407
Fairfield 2.035
Jacksonville 1.584
Chandler 1.580
Houston 1.466
Ann Arbor 1.187
Ashburn 1.035
Wilmington 861
Seattle 820
Cambridge 670
Izmir 516
Nanjing 488
Beijing 399
Princeton 361
Ferrara 263
Boardman 259
Milan 233
Brussels 205
San Diego 171
Nanchang 165
Warsaw 154
Shenyang 151
Dearborn 149
Shanghai 124
Addison 111
Bremen 104
Hebei 98
Tianjin 95
Changsha 93
New York 92
Jiaxing 72
San Mateo 60
Hong Kong 59
Jinan 57
Norwalk 55
Mountain View 51
Zhengzhou 47
Kunming 46
Rome 45
Falls Church 43
London 36
Orange 36
Auburn Hills 35
Düsseldorf 35
Florence 35
Redwood City 35
Philadelphia 32
Ningbo 31
Guangzhou 29
Bologna 28
Vienna 26
Chicago 24
Washington 23
Des Moines 21
Lanzhou 20
Napoli 19
Taizhou 19
Tappahannock 19
Torino 18
Verona 18
Indiana 17
Los Angeles 17
Hefei 16
Hangzhou 15
Dong Ket 14
Bari 13
Helsinki 13
Naples 13
Padova 13
Ferrara di Monte Baldo 12
Haikou 12
Redmond 12
Augusta 11
Kilburn 11
Brno 10
Camerino 9
Livorno 9
Caserta 7
Hounslow 7
Reggio Nell'emilia 7
Ardabil 6
Foggia 6
Monmouth Junction 6
Montebelluna 6
Palermo 6
Aversa 5
Bergamo 5
Changchun 5
Dallas 5
Edinburgh 5
Fuzhou 5
Lucca 5
New Bedfont 5
Parma 5
Toronto 5
Trieste 5
Andover 4
Castelfidardo 4
Leawood 4
Messina 4
Totale 19.289
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.076
A glance at adenosine receptors: Novel target for antitumor therapy 197
PRIN 2007 Coordinatore Nazionale del progetto Dott. Stefania Gessi- Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale 197
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 186
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 169
The A3 adenosine receptor: history and perspectives 158
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 151
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 151
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 149
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 149
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 148
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 148
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 140
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 139
Adenosine receptors and human melanoma 138
Pathological overproduction: the bad side of adenosine 138
Therapeutic potential of adenosine receptor antagonists and agonists 134
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 134
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 131
Pharmacology of Adenosine Receptors: The State of the Art 130
Adenosine receptor targeting in health and disease 129
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 129
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 127
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 125
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 125
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 123
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 121
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 121
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 120
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 119
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 118
null 118
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 118
Adenosine receptors and cancer 117
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 117
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 116
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 116
Synthesis and preliminary biological evaluation of novel N-substituted 1-amino-3-[1-methyl(phenyl)-1H-indazol-4-yloxy]-propan-2-ols interesting as potential antiarrhythmic, local anaesthetic and analgesic agents 116
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 115
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 115
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 114
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 114
null 113
Binding thermodynamics at A1 and A2A adenosine receptors 113
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 113
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 113
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 112
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 112
null 112
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 111
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 111
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 111
New potent and selective human adenosine A3 receptor antagonists. 111
The A3 adenosine receptor: an enigmatic player in cell biology. 110
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 109
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 109
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 109
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 109
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 109
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 108
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 108
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 108
Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands 107
null 107
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 106
Adenosine receptors in health and disease 106
Agonists and antagonists: Molecular mechanisms and therapeutic applications 106
null 106
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 105
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 104
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 104
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 104
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 104
Adenosine and lymphocyte regulation 104
A(2A) adenosine receptors in human peripheral blood cells 103
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 102
Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors 102
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 102
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 102
null 102
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 102
null 102
van't Hoff Based Thermodynamics 102
The P2X7 receptor as a therapeutic target. 101
Synthesis, molecular modeling and opioid receptor affinity of 9,10-diazatricyclo[4.2.1.1 2,5]decanes and 2,7-diazatricyclo[4.4.0.0 3,8]decanes structurally related to 3,8-diazabicyclo[3.2.1]octanes 101
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 101
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 101
Adenosine A2A receptors in human circulating blood elements 100
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 100
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 100
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 100
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 99
Adenosine receptors and cancer 99
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 98
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 98
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 97
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A(3) adenosine receptors 97
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 97
Benzocondensed derivatives as rigid analogues of the μ-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3,2,1]octanes: Synthesis, modeling, and affinity 96
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 96
Totale 12.670
Categoria #
all - tutte 84.647
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.761
Totale 89.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.927 0 0 0 0 0 0 0 0 315 611 673 1.328
2019/20205.495 1.001 158 143 746 318 659 484 550 414 647 281 94
2020/20214.151 397 431 173 487 220 445 145 471 76 563 511 232
2021/20223.182 68 328 207 157 141 135 118 174 113 266 459 1.016
2022/20233.856 360 289 119 500 617 497 202 347 464 50 266 145
2023/20241.378 193 313 104 60 249 217 101 133 8 0 0 0
Totale 27.638